Guro Lind's project group
We focus our research on the cancer epigenome and DNA methylation in particular. By integrating large-scale analyses with detailed candidate gene characterization we aim at identifying DNA methylation biomarkers with clinical impact.
The group is member of "CoE - Centre for Cancer Biomedicine".
![]() | |
| RESEARCH THEMES |
Identification of novel epigenetic biomarkers for early detection of gastrointestinal cancer
Identification and characterization of epigenetic master keys in cancer development
Group contact information:
Department of Cancer Prevention, Institute for Cancer Research
Oslo University Hospital HE - Norwegian Radium Hospital
Mail address: P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway
Street address: Norwegian Radium Hospital, Montebello
Phone: +47 2278 1737
Guro.Elisabeth.Lind@rr-research.no
May 7, 2012
Latest publications
Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer
Dis Colon Rectum, 55 (3), 307-15
PubMed 22469798
The Gap Junction Channel Protein Connexin 43 Is Covalently Modified and Regulated by SUMOylation
J Biol Chem, 287 (19), 15851-61
PubMed 22411987
MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
J Transl Med, 10, 36
PubMed 22390413
More publications






Print this page
